Skip to main content
TipRanks
Go Ultimate75% OFF

Cytek Biosciences (8EQ) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

8EQ Analyst Ratings

Moderate Buy
4Ratings
2Buy2Hold0Sell
Based on 4 analysts giving stock ratings to Cytek Biosciences in the past 3 months

8EQ Stock 12 Month Forecast

€5.46▲(7.01% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Cytek Biosciences in the last 3 months. The average price target is EUR 5.46 with a high forecast of EUR 6.68 and a low forecast of EUR 4.46. The average price target represents a 7.01% change from the last price of EUR 5.10.
Highest Price Target€6.68Average Price Target€5.46Lowest Price Target€4.46

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:8EQ
Price TargetArticle
Stephens€6.24buy22.30%UpsideAssigned11/10/26
Piper Sandler€6.68buy31.04%UpsideReiterated11/05/26
TD Cowen€4.46hold-12.64%DownsideReiterated11/05/26
Morgan Stanley€4.90→€4.46hold-12.64%DownsideReiterated10/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cytek Biosciences

3 Months
David Westenberg
David WestenbergPiper Sandler
Success Rate13/31 ratings generated profit
42%
Average Return
+0.17%

Copying David Westenberg's trades and holding each position for 3 Months would result in 41.94% of your transactions generating a profit, with an average return of +0.17% per trade.

1 Year
David Westenberg
David WestenbergPiper Sandler
Success Rate12/31 ratings generated profit
39%
Average Return
-10.16%

Copying David Westenberg's trades and holding each position for 1 Year would result in 38.71% of your transactions generating a profit, with an average return of -10.16% per trade.

2 Years
David Westenberg
David WestenbergPiper Sandler
Success Rate12/31 ratings generated profit
39%
Average Return
-10.45%

Copying David Westenberg's trades and holding each position for 2 Years would result in 38.71% of your transactions generating a profit, with an average return of -10.45% per trade.

8EQ Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 8EQ
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11110
Buy10013
Hold22232
Sell00000
Strong Sell00000
total43355

In the current month, 8EQ has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 8EQ average Analyst price target in the past 3 months is 5.46.

8EQ Financial Forecast

€-2€-1.25€-0.5€0.25€1Q1 2026Q3 2026Q4 2026
High€0.01
Consensus€0.00
Low€0.00

8EQ Earnings Forecast

Next quarter’s earnings estimate for 8EQ is EUR 0.00 with a range of EUR 0.00 to EUR 0.01. The previous quarter’s EPS was -EUR 0.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€39.5M€44M€48.5M€53M€57.4MQ1 2026Q3 2026Q4 2026
High€57.4M
Consensus€56.7M
Low€56M

8EQ Sales Forecast

Next quarter’s sales forecast for 8EQ is EUR 56.75M with a range of EUR 55.96M to EUR 57.43M. The previous quarter’s sales results were EUR 47.66M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

8EQ Stock Forecast FAQ

What is DE:8EQ’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytek Biosciences’s 12-month average price target is €5.46.
What is DE:8EQ’s upside potential, based on the analysts’ average price target?
Cytek Biosciences has 7.01% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cytek Biosciences a Buy, Sell or Hold?
Cytek Biosciences has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
What is Cytek Biosciences’s share price target?
The average share price target for Cytek Biosciences is €5.46. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €6.68, and the lowest forecast is €4.46. The average share price target represents a 7.01% increase from the current price of €5.1.
What do analysts say about Cytek Biosciences?
Cytek Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Cytek Biosciences?
To buy shares of DE:8EQ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.